APB-A001

N/A

Report date: 2025/01/26 16:54:19

Base Information

Drug NameAPB-A001
Drug Alias NameAb-417anti-CD171 mAb (Apitbio)Ab-612anti-L1CAM mAb (Apitbio)APB-A001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionNeural cell adhesion molecule L1 inhibitors
TargetsNeural cell adhesion molecule L1
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsPancreatic Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApitbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesApitbio Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian NeoplasmsPancreatic Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A